Boston, MA -- (SBWIRE) -- 01/30/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: HEINEKEN N V/S ADR(OTCMKTS:HEINY), Mind Solutions Inc(OTCMKTS:VOIS), Bioheart, Inc.(OTCMKTS:BHRT), Cielo S A(OTCMKTS:CIOXY)
HEINEKEN N V/S ADR(OTCMKTS:HEINY) ended lower -0.82% and complete the day at $31.60. The total number of shares changed hands during the day was 44,321. After opening at $31.59, the stock hit as high as $31.66. However, it traded between $31.41 and $38.72 over the last twelve months. Heineken N.V. engages in brewing and selling beer. It offers beer, cider, soft drinks, and other beverages. The company provides its products through distributors and breweries under the Heineken, Amstel, Anchor, Biere Larue, Bintang, Birra Moretti, Cruzcampo.
Has HEINY Found The Bottom and Ready To Move Up? Find Out Here
Mind Solutions Inc(OTCMKTS:VOIS) closed yesterday at $0.0037, a -15.91% decrease. Around 23.09 million shares were traded, beating an-average trading volume of 6.33 million shares. The company is now valued at around $ 4,955. Mind Solutions, Inc. develops software applications in the United States. It develops software applications using a wireless headset, which reads brainwaves and allows interaction with a computer. The company was founded in 2002 and is based in Long Beach, California.
Has VOIS Found The Bottom And Ready To Gain Momentum? Find Out Here
Bioheart, Inc.(OTCMKTS:BHRT) moved 48.76 percent higher at $0.0180 and traded between $0.01 and $0.02 after opening the day at $0.01. Its performance over the last five days remained 73.08%, which stands at 73.08% for a month. Going back further than one month, 1-year performance after recent close was 73.08%. Bioheart, Inc., a biotechnology company, engages in the discovery, development, and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate is MyoCell, a clinical muscle-derived cell therapy that has completed Phase II-a study and designed to populate regions of scar tissue within a patient?s heart with autologous muscle cells, or cells from a patient?s body, for the purpose of improving cardiac function in chronic heart failure patients.
For How Long BHRT Gloss will Attract Investors? Find out via this report
Cielo S A(OTCMKTS:CIOXY) shares fall, losing -0.54 percent to close at $25.95. The stock is up around -7.32% this year and -6.05% for the last 12 months. Around 25,202 shares changed hands yesterday, lower from an-average trading volume of 91,356 shares. Cielo S.A., through its subsidiaries, operates in the merchant acquiring and payment processing industry in Brazil. It provides services related to credit and debit cards, and other payment methods, as well as related services, such as signing up of merchants and service providers; rental, installation, and maintenance of point of sales equipment; and data capture and processing of electronic and manual transactions.
Will CIOXY Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)